NewTimeSpace News: As of 09:46 on March 6, 2026, Healthcare ETF (512170) rose 2.10%, with the latest price at 0.34 yuan. (The stocks listed above are index constituents only, with no specific recommendation intended.)

In terms of liquidity, Healthcare ETF recorded an intraday turnover rate of 0.9%, with trading volume reaching 246 million yuan. Looking at a longer time frame, as of March 5, the ETF's average daily trading volume over the past week was 712 million yuan, ranking first among comparable funds. (Data source: Wind)

In terms of scale, Healthcare ETF's assets under management grew by 1.277 billion yuan over the past year, achieving significant growth, with the new scale ranking 1st out of 4 comparable funds. (Data source: Wind)

In terms of shares, Healthcare ETF's latest share count reached 81.374 billion shares, hitting a new high for the past six months, and ranking 1st out of 4 comparable funds. (Data source: Wind)

Regarding net capital inflows, Healthcare ETF has recorded consecutive net capital inflows for 4 days, with a single-day high of 455 million yuan in net inflows, totaling 898 million yuan in "capital attraction," with an average daily net inflow of 224 million yuan. (Data source: Wind)

Data shows that leveraged funds continue to build positions. Healthcare ETF's latest margin purchase amount reached 167 million yuan, with the latest margin balance at 1.191 billion yuan. (Data source: Wind)

In terms of return capability, as of March 5, 2026, since its inception, Healthcare ETF's highest monthly return was 29.81%, the longest consecutive rising period was 6 months, the longest consecutive rising gain was 26.58%, and the average return rate during rising months was 6.80%. As of March 5, 2026, Healthcare ETF's annualized excess return over the benchmark since inception was 1.71%.

In terms of drawdown, as of March 5, 2026, Healthcare ETF's relative benchmark drawdown year-to-date was 0.12%.

In terms of fees, Healthcare ETF has a management fee of 0.50% and a custody fee of 0.10%.

In terms of tracking accuracy, as of March 5, 2026, Healthcare ETF's tracking error over the past five years was 0.038%, demonstrating the highest tracking precision among comparable funds.

Notably, the CSI Healthcare Index tracked by this fund is currently at historically low valuations, with the latest price-to-book ratio (PB) at 3.39 times, lower than 86.77% of the time over the past 5 years, indicating outstanding valuation attractiveness.

Healthcare ETF closely tracks the CSI Healthcare Index. The CSI Healthcare Index selects listed company securities from the healthcare industry involved in medical devices, medical services, medical informatization, and other healthcare themes as index samples to reflect the overall performance of healthcare theme listed company securities.

On the news front, the important conference work report was released, proposing that the main expected target for 2026 economic growth is 4.5%-5%, implementing industrial innovation projects, encouraging central state-owned enterprises and state-owned enterprises to take the lead in opening application scenarios, and building emerging pillar industries such as integrated circuits, aerospace, biomedicine, and low-altitude economy.

Southwest Securities stated that the innovative medicine sector has recently seen frequent positive developments. Multiple companies have announced cooperation and licensing agreements, including Frontier Biotechnologies and Harbour BioMed, validating enterprises' R&D capabilities. The total BD deal value for the first two months of 2026 has already exceeded $50 billion, approaching 40% of the full year 2025, with upfront payments exceeding $3 billion, surpassing 40% of 2025. The innovative medicine sector's fundamentals continue to improve.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.